Patents by Inventor Doris Stoermer

Doris Stoermer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune response modifier conjugates
    Patent number: 10472420
    Abstract: The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
    Type: Grant
    Filed: January 20, 2015
    Date of Patent: November 12, 2019
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, George W. Griesgraber, James D. Mendoza, Jason D. Bonk
  • Immune response modifier compositions and methods
    Patent number: 10144735
    Abstract: The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: December 4, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, George W. Griesgraber, Tushar A. Kshirsagar
  • IMMUNE RESPONSE MODIFIER COMPOSITIONS AND METHDOS
    Publication number: 20180305357
    Abstract: The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.
    Type: Application
    Filed: June 25, 2018
    Publication date: October 25, 2018
    Inventors: DORIS STOERMER, GEORGE W. GRIESGRABER, TUSHAR A. KSHIRSAGAR
  • SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
    Publication number: 20180222906
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: April 9, 2018
    Publication date: August 9, 2018
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • Immune response modifier compositions and methods
    Patent number: 10005772
    Abstract: The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: June 26, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, George W. Griesgraber, Tushar A. Kshirsagar
  • Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Patent number: 9938275
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: April 10, 2018
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
    Publication number: 20170129891
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Inventors: Doris Stoermer, Joseph F. Dellaria, JR., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Patent number: 9550773
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: April 13, 2015
    Date of Patent: January 24, 2017
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
    Publication number: 20150218162
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: April 13, 2015
    Publication date: August 6, 2015
    Inventors: Doris Stoermer, Joseph F. Dellaria, JR., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • IMMUNE RESPONSE MODIFIER CONJUGATES
    Publication number: 20150141625
    Abstract: The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
    Type: Application
    Filed: January 20, 2015
    Publication date: May 21, 2015
    Inventors: Doris Stoermer, George W. Griesgraber, James D. Mendoza, Jason D. Bonk
  • Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Patent number: 9006264
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: April 14, 2015
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk
  • Immune response modifier conjugates
    Patent number: 8951528
    Abstract: The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: February 10, 2015
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, George W. Griesgraber, James D. Mendoza, Jason D. Bonk
  • SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
    Publication number: 20140011777
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: September 9, 2013
    Publication date: January 9, 2014
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk
  • Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Patent number: 8541438
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: December 21, 2010
    Date of Patent: September 24, 2013
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES
    Publication number: 20110092477
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: December 21, 2010
    Publication date: April 21, 2011
    Inventors: Doris Stoermer, Joseph F. Dellaria, JR., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Patent number: 7884207
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, [1,5]naphthyridines, [1,5]tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, methods of making these compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: February 8, 2011
    Assignee: 3M Innovative Properties Company
    Inventors: Doris Stoermer, Joseph F. Dellaria, Jr., David T. Amos, Bernhard M. Zimmermann, Luke T. Dressel, Jason D. Bonk, Matthew R. Radmer
  • IMMUNE RESPONSE MODIFIER COMPOSITIONS AND METHODS
    Publication number: 20100158928
    Abstract: The present invention provides an immune response modifier (IRM) composition that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety, wherein the covalent link comprises a labile bond directly attached to the IRM moiety.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 24, 2010
    Inventors: Doris Stoermer, George W. Griesgraber, Tushar A. Kshirsagar
  • 1-AMINO IMIDAZO-CONTAINING COMPOUNDS AND METHODS
    Publication number: 20090270443
    Abstract: Imidazo-containing compounds (e.g., imidazonaphthyridines, imidazopyridines) with an amino substituent at the 1-position, pharmaceutical compositions containing the compounds and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: September 2, 2005
    Publication date: October 29, 2009
    Inventors: Doris Stoermer, Luke T. Dressel, Karl J. Manske, George W. Griesgraber, Bernhard M. Zimmermann, Joseph F. Dellaria, JR.
  • IMMUNE RESPONSE MODIFIER CONJUGATES
    Publication number: 20090035323
    Abstract: The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
    Type: Application
    Filed: February 21, 2007
    Publication date: February 5, 2009
    Inventors: Doris Stoermer, George W. Griesgraber, James D. Mendoza, Jason D. Bonk
  • Substituted Imidazoquinolines, Imidazopyridines, and Imidazonaphthyridines
    Publication number: 20070287724
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems (particularly quinolines, tetrahydroquinolines, pyridines, 1,5-naphthyridines, 1,5-tetrahydronaphthyridines) substituted at the 1-position with a cyclic substituent, pharmaceutical compositions containing the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: June 17, 2005
    Publication date: December 13, 2007
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Doris Stoermer, Joseph Dellaria, David Amos, Bernhard Zimmermann, Luke Dressel, Jason Bonk, Matthew Radmer